Completed PHASE4 INTERVENTIONAL 3-arm NCT03054103

Sedation Methods During Cataract Surgery

A Comparison of Midazolam vs. Midazolam/Ketamine for Conscious Sedation in Patients Undergoing Phacoemulsification Under Topical Anesthesia

Sponsor: Wake Forest University Health Sciences

Conditions Cataract Phacoemulsification

Interventions Midazolam + Ketamine 10 MG/ML: 0.5 ML Midazolam + Ketamine 10 MG/ML: 1 ML Midazolam + Normal saline

Updated 10 times since 2017 Last updated: Aug 9, 2018 Started: May 3, 2016 Primary completion: Nov 5, 2016 Completion: Nov 11, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cataract and Phacoemulsification, this trial is completed. The trial is conducted by Wake Forest University Health Sciences and has accumulated 10 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Dec 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 5 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Oct 2018 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Oct 2018 [monthly]

Completed PHASE4
Feb 2018 — Jun 2018 [monthly]

Completed PHASE4
Feb 2017 — Feb 2018 [monthly]

Completed PHASE4

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wake Forest University Health Sciences

Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.